Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Life Sci Alliance ; 4(2)2021 02.
Article in English | MEDLINE | ID: mdl-33310759

ABSTRACT

Malignant transformation depends on genetic and epigenetic events that result in a burst of deregulated gene expression and chromatin changes. To dissect the sequence of events in this process, we used a T-cell-specific lymphoma model based on the human oncogenic nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) translocation. We find that transformation of T cells shifts thymic cell populations to an undifferentiated immunophenotype, which occurs only after a period of latency, accompanied by induction of the MYC-NOTCH1 axis and deregulation of key epigenetic enzymes. We discover aberrant DNA methylation patterns, overlapping with regulatory regions, plus a high degree of epigenetic heterogeneity between individual tumors. In addition, ALK-positive tumors show a loss of associated methylation patterns of neighboring CpG sites. Notably, deletion of the maintenance DNA methyltransferase DNMT1 completely abrogates lymphomagenesis in this model, despite oncogenic signaling through NPM-ALK, suggesting that faithful maintenance of tumor-specific methylation through DNMT1 is essential for sustained proliferation and tumorigenesis.


Subject(s)
Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , DNA (Cytosine-5-)-Methyltransferase 1/metabolism , Epigenesis, Genetic , Lymphoma/etiology , Lymphoma/metabolism , Protein-Tyrosine Kinases/genetics , Animals , Biomarkers, Tumor , Computational Biology/methods , DNA (Cytosine-5-)-Methyltransferase 1/genetics , DNA Methylation , Disease Models, Animal , Disease Susceptibility , Epigenomics , Gene Deletion , Gene Expression Regulation, Neoplastic , Gene Regulatory Networks , Humans , Immunohistochemistry , Immunophenotyping , Lymphoma/drug therapy , Lymphoma/pathology , Mice , Mice, Knockout , Mice, Transgenic , Protein-Tyrosine Kinases/metabolism , STAT3 Transcription Factor/metabolism , Signal Transduction , Xenograft Model Antitumor Assays
SELECTION OF CITATIONS
SEARCH DETAIL
...